Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- COVID-19 (15)
- SARS-CoV-2 (9)
- Vaccination (7)
- Education (3)
- Pneumonia (3)
-
- Cancer (2)
- Cytokine storm (2)
- HPV (2)
- Infection prevention (2)
- Pandemic (2)
- Pneumothorax (2)
- Vaccine (2)
- ARDS (1)
- Anosmia (1)
- Antibody stabilization (1)
- Antipyretic (1)
- Antisense of genes (1)
- BNP (1)
- Breast milk (1)
- Broadly neutralizing antibodies (1)
- Bronchiectasis (1)
- COPD (1)
- Cardiac biomarkers (1)
- Cardiovascular events (1)
- Case report (1)
- Cervical cancer (1)
- Child health (1)
- Chlamydia (1)
- Chlamydia pneumoniae (1)
- College (1)
- Publication
- Publication Type
Articles 31 - 32 of 32
Full-Text Articles in Viruses
Improving Hpv Vaccination Series Initiation Rates And Compliance Among Indigent Women In South Texas, Ages 19-26, Through Provider Recommendation And Additional Clinic Funding: A Quality Improvement Project, Lacey Cudd
Doctor of Nursing Practice
The purpose of this quality improvement project was to increase human papillomavirus vaccination series initiation rates among indigent women, ages 19-26, at a clinic in South Texas. The human papillomavirus is a sexually transmitted infection that has been associated with multiple types of cancers. Each year, approximately 6.2 million cases of the human papillomavirus infection are diagnosed; as many as 75% of all new infections occur among females 18-26 years of age. The human papillomavirus vaccination has a high efficacy in regards to cancer prevention, preventing as many as 76% of cancers with only one dose. The project included educating …
The Effects Of A Hpv Educational Intervention Aimed At Collegiate Males On Knowledge, Vaccine Intention, And Uptake, Mary A. Knudtson
The Effects Of A Hpv Educational Intervention Aimed At Collegiate Males On Knowledge, Vaccine Intention, And Uptake, Mary A. Knudtson
Evidence-Based Practice Project Reports
Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI) in the United States (US). In 2013, approximately 6% of 19 to 26-year-old males had received at least one dose of the HPV vaccine (Richman, Maddy, Torres, & Goldberg, 2016). Currently there is no known cure for HPV, however a prophylactic vaccination provides an efficacious method for protection against HPV related diseases. The purpose of the evidence-based project was to provide a HPV educational intervention to collegiate males and examine the effects of HPV knowledge, intention to vaccinate, and receipt of vaccination. The Health Belief Model was selected to …